Join us for the 22nd Anniversary of the annual EMBL PhD Symposium. Since its
conception in 1999, the EMBL PhD Symposium has evolved into a highly respected
scientific meeting, connecting young researchers and high-profile scientists
alike. This year, our Symposium centers on the theme
“The Roaring 20s: A New Decade for Life Sciences”.
In the next ten years, vast progress will be achieved within the life sciences and new challenges are emerging. We are dedicated to bring together outstanding researchers from a broad range of disciplines that implement highly promising approaches to tackle the current scientific questions as well as the global problems we face as a scientific community and as humanity. We will address issues ranging from basic research questions in the life sciences to the most recent developments in synthetic biology, disease management and neuroscience. Furthermore, we will address the intricate relationship between living organisms and their environment - thus focusing on ecology and evolution – and on the discussion about how to communicate our science to the society we are part of.
Come and join us at the 22nd EMBL PhD Symposium, for three days of exciting and future-oriented science.
We are aware that the current situation causes many insecurities concerning registration for and participation in our conference. Since the symposium takes place at the end of November, we will try our best to host the conference on site. However, taking everyone’s safety and security into account there will be the option to take it virtually (online participation, remote presentation) if the situation does not improve over the next few months. For more information please click here. This information is constantly updated.
University of Vienna
Christa Schleper is professor at the University of Vienna, Austria, since 2007 and head of the Archaea Biology and Ecogenomics Unit. She studies the ecology, physiology, molecular biology and evolution of Archaea. Schleper has worked at the MPI Martinsried, at Caltech and Univ. of Sta Barbara, at the University of Darmstadt, and as full professor at the University of Bergen, before she moved to Vienna. She is an EMBO member and in the Austrian Academy of Sciences, received an ERC Advanced Grant in 2016, and was highly cited researcher in 2019. She is also a co-organizer of the new Climate Change and Climate Crisis lecture in Vienna.
Jean-Léon Maître is a group leader at the institut Cure in Paris, France studying mammalian pre-implantation development with a focus on cell mechanics and cell-cell interactions. Jean-Léon received a PhD in the laboratory of Carl-Philipp Heisenberg at the Max Planck Institute for Cell Biology and Genetics (Dresden, Germany) and the Institute of Science and Technology Austria (Klosterneuburg, Austria) for his work on cell cortex tension and cell adhesion during zebrafish gastrulation. During his postdoc at EMBL Heidelberg with Takashi Hiiragi, he worked on the mechanics of the pre-implantation embryo in the mouse supported by an EMBO long term fellowship and a Marie Curie IntraEuropean fellowship. Jean-Leon was awarded an ERC starting grant in 2017 and is an EMBO young investigator.
MRC Laboratory of Molecular Biology
Kelly Nguyen earned her PhB (Honours) degree in chemistry from the Australian National University, followed by a PhD in structural biology from the MRC-LMB (Cambridge, UK) with Dr Kiyoshi Nagai. She was awarded a Miller Research Fellowship in 2016 to work on human telomerase in the laboratories of Profs. Eva Nogales and Kathleen Collins at the University of California, Berkeley. In 2019, she established her own group at the MRC-LMB. Kelly Nguyen’s group studies telomerase regulation and other processes involved in telomere maintenance beyond telomerase. She employs an integrated structural biology approach with a focus on biochemistry, cryo-electron microscopy and in vivo studies.
University of Tübingen
Dr. Lisa Maier did her PhD in the lab of Prof. Dr. W.-D. Hardt at ETH Zürich, Switzerland, where she studied the role of the microbiota during Salmonella Typhimurium induced colitis. "The influence of non-digestible carbohydrates on the intestinal colonization with enteropathogens" was the topic of research during her first post-doc in the same lab in 2014. From 2015 to 2018 Dr. Lisa Maier studied "drug-microbe interactions in the human gut microbiome" in the lab of Dr. A. Typas and Dr. K. Patil at EMBL Heidelberg. In her first-author publication in Nature in 2018, the potential risk of non-antibiotics promoting antibiotic resistance has been shown. Currently, starting from 2019, Dr. Lisa Maier is independent junior research group leader at University of Tübingen.
University College London
Matteo Carandini is the GlaxoSmithKline / Fight for Sight Professor of Visual Neuroscience at University College London (UCL), where he co-directs a laboratory together with Kenneth Harris. His research focuses on the computations performed by large populations of neurons in the mouse brain. Carandini holds a Laurea summa cum laude in Mathematics from the University of Rome and a PhD in Neural Science from New York University. Before joining UCL in 2007, he ran laboratories in Zurich and San Francisco. He is a leader of the Neuropixels consortium and a founding member of the International Brain Laboratory.
Miguel Nicolelis, M.D., Ph.D., is the Duke School of Medicine Distinguished Professor of Neuroscience at Duke University, Professor of Neurobiology, Biomedical Engineering, Neurology, Neurosurgery and Psychology and Neuroscience, and founder of Duke's Center for Neuroengineering. He is Founder and Scientific Director of the Edmond and Lily Safra International Institute for Neuroscience of Natal. Dr. Nicolelis is also founder of the Walk Again Project, an international consortium of scientists and engineers, dedicated to the development of an exoskeleton device to assist severely paralyzed patients in regaining full body mobility. Dr. Nicolelis has dedicated his career to investigating how the brains of freely behaving animals encode sensory and motor information. As a result of his studies, Dr. Nicolelis was first to propose and demonstrate that animals and human subjects can utilize their electrical brain activity to directly control neuroprosthetic devices via brain-machine interfaces (BMI).Dr. Nicolelis is a member of the French and Brazilian Academies of Science and has authored over 200 manuscripts, edited numerous books and special journal publications, and holds three US patents.
Muzlifah Haniffa is a Wellcome Trust Senior Research Fellow, Lister Institute Research Fellow and Consultant Dermatologist based in Newcastle University. She graduated from medical school in Cardiff and trained as a junior doctor in Cambridge. She received her dermatology specialist training in Newcastle. She was awarded an Action Medical Research Training Fellowship and a Wellcome Trust Clinical Intermediate Fellowship. Muzz was the recipient of the Academy of Medical Sciences Foulkes Foundation Medal (2019) and the European Federation of Immunological Societies ACTERIA Prize in Immunology and Allergology (2018). Muzz is a leading member of the Human Cell Atlas initiative and pioneered the application of single cell genomics to decode the developing human immune system, and the human skin in health and disease. She is passionate about mentoring and diversity in science.
The University of Edinburgh
Dr. Nadanai Laohakunakorn, originally from Bangkok, obtained his BA/MSci in Natural Sciences (Physics) from Trinity College, Cambridge in 2010. He remained in Cambridge to carry out his PhD under the supervision of Prof Ulrich Keyser, where he studied nanopores and single-molecule biophysics. In particular, his work focused on electrically-driven fluid flows generated within the confined geometries of nanopores, and he developed techniques to measure and characterise these effects using optical tweezers. After defending his thesis in 2015, he moved to Lausanne where he worked with Prof Sebastian Maerkl at EPFL, on the new and growing field of cell-free synthetic biology. His work there focused on combining microfluidic devices with cell-free gene expression systems for high-throughput and rapid prototyping of genetic parts and circuits. In 2019 he received a Chancellor's Fellowship in Biotechnology at the University of Edinburgh, where he has established a lab for quantitative and automated engineering of cell-free systems.
|08:00 - 09:00||Registration|
|09:00 - 09:30||Symposium Opening & Welcome
|9:30 - 12:30||Details to be announced|
|12:30 - 13:30||Lunch + Meet the Speakers|
|13:30 - 14:30||Details to be announced|
|14:00 - 17:00||Details to be announced|
|17:00 - 18:00||Workshops - Details to be announced||18:00 - 19:00||Dinner|
|20:00 - 22:00||Evening Programme: Tour of Heidelberg and Pub Visit
|09:00 - 12:00||Details to be announced|
|12:00 - 13:00||Ecology & Environment Talk / Panel Discussion|
|13:00 - 14:00||Lunch + Meet the Speakers|
|14:00 - 17:00||Details to be announced|
|17:00 - 17:15||Flash Talks|
|17:15 - 19:00||Poster Session|
|19:00 - 20:00||Dinner|
|20:00 - 22:00||Evening Programme|
|10:00 - 12:45||Details to be announced|
|12:45 - 13:00||Flash Talks|
|13:00 - 14:00||Lunch + Meet the Speakers|
|14:00 - 15:00||Poster Session|
|15:00 - 16:00||Details to be announced|
|16:00 - 19:45||Details to be announced|
|19:45 - 20:00||Awards and Thank You's|
|20:00 - 21:00||Dinner|
|21:00 - 01:00||Symposium Party|
Heidelberg is easily reached by train, car or plane from any country in the world. The EMBL campus is located in the neighbourhood area of Boxberg which is approximately 10 minutes by car from Heidelberg's city centre.Reaching us by train, plane, or car.
Prior to travelling to Germany, some applicants from certain countries may have to acquire special travel documents, such as a visa. Applicants are strongly encouraged to check with the local German Authorities (Embassies or Consulates) about the need for special travelling documents. Since the process may be time consuming, applicants are advised to make such arrangements as soon as possible. Failure to obtain a visa after the deadline for participation in the conference will not result in a refund. Applicants are responsible for providing the right documentation needed for their entry into Germany. However, upon request, the Organising Committee can issue a formal letter of acceptance to the symposium for the purposes of obtaining a visa. Please be aware that no visa letters will be issued before payment of the registration fee. The organising committee can not be held responsible in the case of a refusal by German authorities to enter German territory.
The registration fee does not include accommodation, which has to be
personally arranged. Buses to EMBL from Heidelberg downtown will be provided during the symposium.
There are a number of options for obtaining a travel grant:
Please note that you need to apply independently to these grants.
If you require any assistance please do not hesitate to contact the Symposium Organisers.
|Abstract submission / Financial Support application:||September 03rd|
|Short talk and Fellowship selection:||September 24th|
Note: Abstracts for Posters can be submitted until the registration deadline.
|Bachelor's / Master's students||130€||Register|
|Academia (PhD students, etc.)||180€||Register||Day Tickets||80€||Register|
|EMBL Staff (including new EMBL PhD Students)||Register|
Follow us on our social media accounts to stay tuned!
The EMBL PhD symposium will provide an invaluable networking environment for your company to enhance the profile amongst the molecular biosciences research community, especially towards the young generation. The symposium will offer prime opportunities for your company to promote your new products, latest technology, and services. If you are interested in sponsoring our symposium and would like to have more information, direct your enquires to us.